Madrigal Pharmaceuticals, Inc.
At Close: 4:00 PM
MDGL Stock Price Graph
MDGL Stock Price Today
Madrigal Pharmaceuticals, Inc. (MDGL) stock rallied over 3.58% intraday to trade at $197.3 a share on NASDAQ. The stock opened with a loss of -36.20% at $124.77 and touched an intraday high of $124.87, rising 0.89% against the last close of $195.56. The Madrigal Pharmaceuticals, Inc. in stock market went to a low of $119.76 during the session.
MDGL Stock Snapshot
Number of Shares
Cash Flow per Share
Free Float in %
MDGL Stock Price History Chart
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III clinical trials for the treatment of non-alcoholic steatohepatitis. The company also develops MGL-3745, a backup compound to resmetirom. It has research, development, and commercialization agreement with Hoffmann-La Roche. Madrigal Pharmaceuticals, Inc. is headquartered in West Conshohocken, Pennsylvania.
Frequently Asked Questions
What is the current Madrigal Pharmaceuticals, Inc. (MDGL) stock price?
Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) stock price is $197.30 in the last trading session. During the trading session, MDGL stock reached the peak price of $124.87 while $119.76 was the lowest point it dropped to. The percentage change in MDGL stock occurred in the recent session was 3.58% while the dollar amount for the price change in MDGL stock was $6.82.
MDGL's industry and sector of operation?
The NASDAQ listed MDGL is part of Biotechnology industry that operates in the broader Healthcare sector. Madrigal Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases.
Who are the executives of MDGL?
Dr. Kianoush Motesharei Ph.d.
Senior Vice President of Bus. & Corporation Devel.
Mr. Remy Sukhija
Senior Vice President & Chief Commercial Officer
Dr. Paul A. Friedman M.D.
Chairman & Chief Executive Officer
Mr. Brian J. Lynch J.D.
Senior Vice President & Gen. Counsel
How MDGL did perform over past 52-week?
MDGL's closing price is 4.40% higher than its 52-week low of $57.21 where as its distance from 52-week high of $322.67 is -0.04%.
How many employees does MDGL have?
Number of MDGL employees currently stands at N/A. MDGL operates from Four Tower Bridge, West Conshohocken, PA 19428, US.
Link for MDGL official website?
Official Website of MDGL is: https://www.madrigalpharma.com
How do I contact MDGL?
How many shares of MDGL are traded daily?
MDGL stock volume for the day was 269281.00 shares. The average number of MDGL shares traded daily for last 3 months was 453.47 Thousands.
What is the market cap of MDGL currently?
The market value of MDGL currently stands at $3.89 Billion with its latest stock price at $197.30 and N/A of its shares outstanding.